Celalettin Ustun to Myelodysplastic Syndromes
This is a "connection" page, showing publications Celalettin Ustun has written about Myelodysplastic Syndromes.
Connection Strength
0.339
-
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors. JAMA Oncol. 2022 Mar 01; 8(3):404-411.
Score: 0.198
-
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes. Biol Blood Marrow Transplant. 2017 Jun; 23(6):971-979.
Score: 0.141